Press Releases

Nanoscope Therapeutics Press Releases

Nanoscope’s Optical Gene Therapies to be Featured at Optogenetics and Optical Manipulation 2021 Conference
March 5, 2021 by Nanoscope Therapeutics
Nanoscope President to Deliver Talk on Gene Therapy for Retinal Diseases at Association for Ocular Pharmacology and Therapeutics Conference
March 3, 2021 by Nanoscope Therapeutics
Nanoscope® team conferred Phase II Retinal Organoid Challenge (ROC) award by National Institute of Health
February 2, 2021 by Nanoscope Therapeutics
Nanoscope Therapeutics Receives Orphan Drug Designation for Gene Therapy of Blindness
January 25, 2021 by Nanoscope Therapeutics
Nanoscope Announces Presentation at the 2020 Annual Meeting of American Academy of Ophthalmology
November 13, 2020 by Nanoscope Therapeutics
Nanoscope received NIH support for its first-in-class delivery approach to restore vision
May 28, 2020 by Nanoscope Therapeutics
Nanoscope Receives NIH grants to recruit talent and advance optogenetic delivery platforms
January 25, 2020 by Nanoscope Therapeutics

Samarendra Mohanty (Co-Founder/President) has decades of Biomedical Technologies experience in Asia, Europe and USA. He has authored over 200 publications and patents. He is the Primary Investigator for major grants from National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs international conference on optogenetics. He is winner of 2019 Healthcare Heroes award.

Nanoscope Therapeutics Press Releases

Dr. Samarendra Mohanty, PhD | Co-Founder & President